Parker Institute and Cancer Vaccine Coalition Join Forces to Revolutionize Cancer Treatment The Parker Institute for Cancer Immunotherapy and Cancer Vaccine Coalition are teaming up to accelerate cancer vaccine development, promising new breakthroughs in cancer treatment.

Parker Institute and Cancer Vaccine Coalition Join Forces to Revolutionize Cancer Treatment #USA #San_Francisco #Cancer_Research #Cancer_Vaccine_Coalition #Parker_Institute

Parker Institute Strengthens Leadership with Bolyn Hubby's Appointment as Chief of Staff The Parker Institute for Cancer Immunotherapy has appointed Bolyn Hubby, Ph.D., as Chief of Staff, focusing on strategic growth and organizational excellence.

Parker Institute Strengthens Leadership with Bolyn Hubby's Appointment as Chief of Staff #Cancer_Research #Parker_Institute #Bolyn_Hubby

Parker Institute for Cancer Immunotherapy Appoints Bob Purcell as New Chief Communications Officer Bob Purcell has been appointed as Chief Communications Officer at the Parker Institute for Cancer Immunotherapy, bringing extensive experience in biotech communications.

Parker Institute for Cancer Immunotherapy Appoints Bob Purcell as New Chief Communications Officer #United_States #San_Francisco #Cancer_Immunotherapy #Parker_Institute #Bob_Purcell

Parker Institute Partners with ASCO to Enhance Cancer Research Through Young Investigator Award The Parker Institute for Cancer Immunotherapy collaborates with ASCO to fund an award supporting early-career oncologists in groundbreaking cancer research.

Parker Institute Partners with ASCO to Enhance Cancer Research Through Young Investigator Award #USA #San_Francisco #ASCO #Parker_Institute #Conquer_Cancer

Mark Veich Appointed as Chief Organizational Advancement Officer at PICI Mark Veich has been named Chief Organizational Advancement Officer at the Parker Institute for Cancer Immunotherapy, enhancing fundraising and strategic growth.

Mark Veich Appointed as Chief Organizational Advancement Officer at PICI #USA #San_Francisco #Cancer_Immunotherapy #Parker_Institute #Mark_Veich

Parker Institute Showcases Pioneering Advances in Immunotherapy at SITC 2025 Annual Meeting At the 2025 SITC Annual Meeting, the Parker Institute for Cancer Immunotherapy highlights new advancements and honors key contributors in the field of cancer research.

Parker Institute Showcases Pioneering Advances in Immunotherapy at SITC 2025 Annual Meeting #USA #Cancer_Immunotherapy #National_Harbor #Parker_Institute #SITC_2025

Karen Knudsen: New Leadership Era for Parker Institute for Cancer Immunotherapy Karen E. Knudsen, MBA PhD, has been named CEO of the Parker Institute for Cancer Immunotherapy, poised to enhance cancer research and treatment innovation.

Karen Knudsen: New Leadership Era for Parker Institute for Cancer Immunotherapy #USA #San_Francisco #Cancer_Immunotherapy #Parker_Institute #Karen_Knudsen